Twenty-three new human tumor lines established in nude mice

J. Fogh, T. Orfeo, J. Tiso, Francis E Sharkey, J. M. Fogh, W. P. Daniels

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Subcutaneous inoculation of 87 human tumors into athymic nude mice, including gastrointestinal (non-colon) tumors, germ cell-primitive cell tumors, kidney tumors, lower urinary tract tumors, malignant melanomas and several metastases from unknown primary sites, resulted in growth in primary transplants in 32 cases (36.8%). Take rates varied among the tumor categories, from 56% for malignant melanomas to 13% for lower urinary tract tumors. They also differed among recurrent tumors (50%), metastases (41%) and tumors of primary site (28%). 23 tumor lines were established, including 5 lines each from renal cell adenocarcinomas and malignant melanomas, 2 each from adenocarcinoma of the pancreas and Wilms' tumors and only one line each from various tumors of the gastrointestinal, germ cell-primitive cell, lower urinary tract and primary site unknown categories. The frequency of line establishment was greater for recurrent tumors and metastases than for primary tumors. Tumor lines have been carried continuously up to passage 17 in one case. Time in primary transplant varied from 3 to 29 weeks for the individual tumors and the average primary transplant time varied from 5.8 to 14.7 weeks for the 6 tumor categories. The average time in passage varied among the established lines from 2.3 to 10.6 weeks. The average passage time for all tumor lines was 5.3 weeks, with those of recurrent tumor origin showing the shortest average (4.0 weeks) followed by lines of metastatic origin (5.4 weeks) and those of primary tumor origin (5.8 weeks).

Original languageEnglish (US)
Pages (from-to)229-239
Number of pages11
JournalExperimental Cell Biology
Volume48
Issue number3
StatePublished - 1980
Externally publishedYes

Fingerprint

Nude Mice
Neoplasms
Urinary Tract
Melanoma
Germ Cell and Embryonal Neoplasms
Neoplasm Metastasis
Transplants
Wilms Tumor
Renal Cell Carcinoma
Pancreas

ASJC Scopus subject areas

  • Cell Biology

Cite this

Fogh, J., Orfeo, T., Tiso, J., Sharkey, F. E., Fogh, J. M., & Daniels, W. P. (1980). Twenty-three new human tumor lines established in nude mice. Experimental Cell Biology, 48(3), 229-239.

Twenty-three new human tumor lines established in nude mice. / Fogh, J.; Orfeo, T.; Tiso, J.; Sharkey, Francis E; Fogh, J. M.; Daniels, W. P.

In: Experimental Cell Biology, Vol. 48, No. 3, 1980, p. 229-239.

Research output: Contribution to journalArticle

Fogh, J, Orfeo, T, Tiso, J, Sharkey, FE, Fogh, JM & Daniels, WP 1980, 'Twenty-three new human tumor lines established in nude mice', Experimental Cell Biology, vol. 48, no. 3, pp. 229-239.
Fogh J, Orfeo T, Tiso J, Sharkey FE, Fogh JM, Daniels WP. Twenty-three new human tumor lines established in nude mice. Experimental Cell Biology. 1980;48(3):229-239.
Fogh, J. ; Orfeo, T. ; Tiso, J. ; Sharkey, Francis E ; Fogh, J. M. ; Daniels, W. P. / Twenty-three new human tumor lines established in nude mice. In: Experimental Cell Biology. 1980 ; Vol. 48, No. 3. pp. 229-239.
@article{f473d1df559447fb8c574e25acbe3270,
title = "Twenty-three new human tumor lines established in nude mice",
abstract = "Subcutaneous inoculation of 87 human tumors into athymic nude mice, including gastrointestinal (non-colon) tumors, germ cell-primitive cell tumors, kidney tumors, lower urinary tract tumors, malignant melanomas and several metastases from unknown primary sites, resulted in growth in primary transplants in 32 cases (36.8{\%}). Take rates varied among the tumor categories, from 56{\%} for malignant melanomas to 13{\%} for lower urinary tract tumors. They also differed among recurrent tumors (50{\%}), metastases (41{\%}) and tumors of primary site (28{\%}). 23 tumor lines were established, including 5 lines each from renal cell adenocarcinomas and malignant melanomas, 2 each from adenocarcinoma of the pancreas and Wilms' tumors and only one line each from various tumors of the gastrointestinal, germ cell-primitive cell, lower urinary tract and primary site unknown categories. The frequency of line establishment was greater for recurrent tumors and metastases than for primary tumors. Tumor lines have been carried continuously up to passage 17 in one case. Time in primary transplant varied from 3 to 29 weeks for the individual tumors and the average primary transplant time varied from 5.8 to 14.7 weeks for the 6 tumor categories. The average time in passage varied among the established lines from 2.3 to 10.6 weeks. The average passage time for all tumor lines was 5.3 weeks, with those of recurrent tumor origin showing the shortest average (4.0 weeks) followed by lines of metastatic origin (5.4 weeks) and those of primary tumor origin (5.8 weeks).",
author = "J. Fogh and T. Orfeo and J. Tiso and Sharkey, {Francis E} and Fogh, {J. M.} and Daniels, {W. P.}",
year = "1980",
language = "English (US)",
volume = "48",
pages = "229--239",
journal = "Pathobiology",
issn = "1015-2008",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Twenty-three new human tumor lines established in nude mice

AU - Fogh, J.

AU - Orfeo, T.

AU - Tiso, J.

AU - Sharkey, Francis E

AU - Fogh, J. M.

AU - Daniels, W. P.

PY - 1980

Y1 - 1980

N2 - Subcutaneous inoculation of 87 human tumors into athymic nude mice, including gastrointestinal (non-colon) tumors, germ cell-primitive cell tumors, kidney tumors, lower urinary tract tumors, malignant melanomas and several metastases from unknown primary sites, resulted in growth in primary transplants in 32 cases (36.8%). Take rates varied among the tumor categories, from 56% for malignant melanomas to 13% for lower urinary tract tumors. They also differed among recurrent tumors (50%), metastases (41%) and tumors of primary site (28%). 23 tumor lines were established, including 5 lines each from renal cell adenocarcinomas and malignant melanomas, 2 each from adenocarcinoma of the pancreas and Wilms' tumors and only one line each from various tumors of the gastrointestinal, germ cell-primitive cell, lower urinary tract and primary site unknown categories. The frequency of line establishment was greater for recurrent tumors and metastases than for primary tumors. Tumor lines have been carried continuously up to passage 17 in one case. Time in primary transplant varied from 3 to 29 weeks for the individual tumors and the average primary transplant time varied from 5.8 to 14.7 weeks for the 6 tumor categories. The average time in passage varied among the established lines from 2.3 to 10.6 weeks. The average passage time for all tumor lines was 5.3 weeks, with those of recurrent tumor origin showing the shortest average (4.0 weeks) followed by lines of metastatic origin (5.4 weeks) and those of primary tumor origin (5.8 weeks).

AB - Subcutaneous inoculation of 87 human tumors into athymic nude mice, including gastrointestinal (non-colon) tumors, germ cell-primitive cell tumors, kidney tumors, lower urinary tract tumors, malignant melanomas and several metastases from unknown primary sites, resulted in growth in primary transplants in 32 cases (36.8%). Take rates varied among the tumor categories, from 56% for malignant melanomas to 13% for lower urinary tract tumors. They also differed among recurrent tumors (50%), metastases (41%) and tumors of primary site (28%). 23 tumor lines were established, including 5 lines each from renal cell adenocarcinomas and malignant melanomas, 2 each from adenocarcinoma of the pancreas and Wilms' tumors and only one line each from various tumors of the gastrointestinal, germ cell-primitive cell, lower urinary tract and primary site unknown categories. The frequency of line establishment was greater for recurrent tumors and metastases than for primary tumors. Tumor lines have been carried continuously up to passage 17 in one case. Time in primary transplant varied from 3 to 29 weeks for the individual tumors and the average primary transplant time varied from 5.8 to 14.7 weeks for the 6 tumor categories. The average time in passage varied among the established lines from 2.3 to 10.6 weeks. The average passage time for all tumor lines was 5.3 weeks, with those of recurrent tumor origin showing the shortest average (4.0 weeks) followed by lines of metastatic origin (5.4 weeks) and those of primary tumor origin (5.8 weeks).

UR - http://www.scopus.com/inward/record.url?scp=0018861587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018861587&partnerID=8YFLogxK

M3 - Article

C2 - 7371899

AN - SCOPUS:0018861587

VL - 48

SP - 229

EP - 239

JO - Pathobiology

JF - Pathobiology

SN - 1015-2008

IS - 3

ER -